The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.
Different pathogens share similar medical settings and rely on similar virulence strategies to cause infections. We have previously applied 3-D computational modeling and bioinformatics to discover novel antigens that target more than one human pathogen. Active and passive immunization with the reco...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-05-01
|
| Series: | PLoS Pathogens |
| Online Access: | http://europepmc.org/articles/PMC5963808?pdf=render |
| _version_ | 1819236883461308416 |
|---|---|
| author | Priya Uppuluri Lin Lin Abdullah Alqarihi Guanpingsheng Luo Eman G Youssef Sondus Alkhazraji Nannette Y Yount Belal A Ibrahim Michael Anthony Bolaris John E Edwards Marc Swidergall Scott G Filler Michael R Yeaman Ashraf S Ibrahim |
| author_facet | Priya Uppuluri Lin Lin Abdullah Alqarihi Guanpingsheng Luo Eman G Youssef Sondus Alkhazraji Nannette Y Yount Belal A Ibrahim Michael Anthony Bolaris John E Edwards Marc Swidergall Scott G Filler Michael R Yeaman Ashraf S Ibrahim |
| author_sort | Priya Uppuluri |
| collection | DOAJ |
| description | Different pathogens share similar medical settings and rely on similar virulence strategies to cause infections. We have previously applied 3-D computational modeling and bioinformatics to discover novel antigens that target more than one human pathogen. Active and passive immunization with the recombinant N-terminus of Candida albicans Hyr1 (rHyr1p-N) protect mice against lethal candidemia. Here we determine that Hyr1p shares homology with cell surface proteins of the multidrug resistant Gram negative bacterium, Acinetobacter baumannii including hemagglutinin (FhaB) and outer membrane protein A (OmpA). The A. baumannii OmpA binds to C. albicans Hyr1p, leading to a mixed species biofilm. Deletion of HYR1, or blocking of Hyr1p using polyclonal antibodies, significantly reduce A. baumannii binding to C. albicans hyphae. Furthermore, active vaccination with rHyr1p-N or passive immunization with polyclonal antibodies raised against specific peptide motifs of rHyr1p-N markedly improve survival of diabetic or neutropenic mice infected with A. baumannii bacteremia or pneumonia. Antibody raised against one particular peptide of the rHyr1p-N sequence (peptide 5) confers majority of the protection through blocking A. baumannii invasion of host cells and inducing death of the bacterium by a putative iron starvation mechanism. Anti-Hyr1 peptide 5 antibodies also mitigate A. baumannii /C. albicans mixed biofilm formation in vitro. Consistent with our bioinformatic analysis and structural modeling of Hyr1p, anti-Hyr1p peptide 5 antibodies bound to A. baumannii FhaB, OmpA, and an outer membrane siderophore binding protein. Our studies highlight the concept of cross-kingdom vaccine protection against high priority human pathogens such as A. baumannii and C. albicans that share similar ecological niches in immunocompromised patients. |
| first_indexed | 2024-12-23T13:11:31Z |
| format | Article |
| id | doaj.art-100150df04e849208bce94ce12f9ddd6 |
| institution | Directory Open Access Journal |
| issn | 1553-7366 1553-7374 |
| language | English |
| last_indexed | 2024-12-23T13:11:31Z |
| publishDate | 2018-05-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Pathogens |
| spelling | doaj.art-100150df04e849208bce94ce12f9ddd62022-12-21T17:45:43ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742018-05-01145e100705610.1371/journal.ppat.1007056The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.Priya UppuluriLin LinAbdullah AlqarihiGuanpingsheng LuoEman G YoussefSondus AlkhazrajiNannette Y YountBelal A IbrahimMichael Anthony BolarisJohn E EdwardsMarc SwidergallScott G FillerMichael R YeamanAshraf S IbrahimDifferent pathogens share similar medical settings and rely on similar virulence strategies to cause infections. We have previously applied 3-D computational modeling and bioinformatics to discover novel antigens that target more than one human pathogen. Active and passive immunization with the recombinant N-terminus of Candida albicans Hyr1 (rHyr1p-N) protect mice against lethal candidemia. Here we determine that Hyr1p shares homology with cell surface proteins of the multidrug resistant Gram negative bacterium, Acinetobacter baumannii including hemagglutinin (FhaB) and outer membrane protein A (OmpA). The A. baumannii OmpA binds to C. albicans Hyr1p, leading to a mixed species biofilm. Deletion of HYR1, or blocking of Hyr1p using polyclonal antibodies, significantly reduce A. baumannii binding to C. albicans hyphae. Furthermore, active vaccination with rHyr1p-N or passive immunization with polyclonal antibodies raised against specific peptide motifs of rHyr1p-N markedly improve survival of diabetic or neutropenic mice infected with A. baumannii bacteremia or pneumonia. Antibody raised against one particular peptide of the rHyr1p-N sequence (peptide 5) confers majority of the protection through blocking A. baumannii invasion of host cells and inducing death of the bacterium by a putative iron starvation mechanism. Anti-Hyr1 peptide 5 antibodies also mitigate A. baumannii /C. albicans mixed biofilm formation in vitro. Consistent with our bioinformatic analysis and structural modeling of Hyr1p, anti-Hyr1p peptide 5 antibodies bound to A. baumannii FhaB, OmpA, and an outer membrane siderophore binding protein. Our studies highlight the concept of cross-kingdom vaccine protection against high priority human pathogens such as A. baumannii and C. albicans that share similar ecological niches in immunocompromised patients.http://europepmc.org/articles/PMC5963808?pdf=render |
| spellingShingle | Priya Uppuluri Lin Lin Abdullah Alqarihi Guanpingsheng Luo Eman G Youssef Sondus Alkhazraji Nannette Y Yount Belal A Ibrahim Michael Anthony Bolaris John E Edwards Marc Swidergall Scott G Filler Michael R Yeaman Ashraf S Ibrahim The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection. PLoS Pathogens |
| title | The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection. |
| title_full | The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection. |
| title_fullStr | The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection. |
| title_full_unstemmed | The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection. |
| title_short | The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection. |
| title_sort | hyr1 protein from the fungus candida albicans is a cross kingdom immunotherapeutic target for acinetobacter bacterial infection |
| url | http://europepmc.org/articles/PMC5963808?pdf=render |
| work_keys_str_mv | AT priyauppuluri thehyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT linlin thehyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT abdullahalqarihi thehyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT guanpingshengluo thehyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT emangyoussef thehyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT sondusalkhazraji thehyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT nannetteyyount thehyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT belalaibrahim thehyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT michaelanthonybolaris thehyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT johneedwards thehyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT marcswidergall thehyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT scottgfiller thehyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT michaelryeaman thehyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT ashrafsibrahim thehyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT priyauppuluri hyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT linlin hyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT abdullahalqarihi hyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT guanpingshengluo hyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT emangyoussef hyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT sondusalkhazraji hyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT nannetteyyount hyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT belalaibrahim hyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT michaelanthonybolaris hyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT johneedwards hyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT marcswidergall hyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT scottgfiller hyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT michaelryeaman hyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection AT ashrafsibrahim hyr1proteinfromthefunguscandidaalbicansisacrosskingdomimmunotherapeutictargetforacinetobacterbacterialinfection |